SHANGHAI, Dec. 12, 2025 -- Under the theme "Imaging the Individual", RSNA 2025 challenged the radiology community to push into new frontiers and close the gap between personalized care and global health disparities. This year, United Imaging Intelligence (UII), the AI-focused subsidiary of United Imaging Group, framed that vision with a timely question: "Agent Radiologist: Are We There Yet?" The company invited attendees to experience a new generation of AI agents capable of understanding, reasoning, and acting across the entire care pathway, bringing more precise and acce
NEW YORK, Dec. 12, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Chipotle Mexican Grill Rings NYSE Bell Amid Its Expansion Kristen Scholer delivers the pre-market update on December 12th The Dow Jones is mixed early Friday, following a session where the S&P 500 and Russell 2000 hit record highs. Analysts say the rally's broadening is a healthy sign for the bul
[ 메디채널 김갑성 기자 ] — LivingPhoenix Forum's 12 Conference Presentation Ignite International and Domestic Academia, Hailed by Academicians as the "iPhone Moment for Extracellular Matrix Research" CHENGDU, China, Dec. 12, 2025 -- LivingPhoenix Regenerative Technologies has drawn widespread international attention this November, presenting its world-first triple-helix biomimetic collagen across 12 high-level academic conferences. These events spanned over diverse fields including aesthetic medicine, regenerative medicine, biomaterials, and personal care. Leading academicians, reno
NANTONG, China, Dec. 12, 2025 -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18 at Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences in Beijing. This milestone marks a transformative moment in the fight against Duchenne Muscular Dystrophy (DMD), positioning RAG-18 as a potential game-changer for the field. By utilizing a novel saRNA mechanism to upregulate UTRN expression, RAG-18 represents a revolutionary
BEIJING, Dec. 12, 2025 -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company") today announced that its wholly owned subsidiary, Beijing REIT Equipment Technology Co., Ltd. ("REIT Equipment"), is participating in Excon 2025, a major construction equipment exhibition in Bangalore, India. REIT Equipment is showcasing its advanced concrete equipment and intelligent solutions at the event. Excon 2025, hosted in Bangalore's tech and manufacturing hub, provides REIT Equipment with a key platform to engage with global industry professionals and poten
70 Embassies Unite to Celebrate Global Culture and Traditions at the Ronald Reagan Building and International Trade Center in Washington, DC WASHINGTON, Dec. 12, 2025 -- On Tuesday, December 9, 2025, the 12th Annual Embassy Showcase, Winternational, presented by World Trade Center Washington, DC (WTCDC), gathered 70 embassies and cultural organizations and welcomed 8,000 guests to celebrate international culture, tourism, and trade at the Ronald Reagan Building and International Trade Center (RRB/ITC). "Winternational is a vibrant celebration of culture, dip
NANTONG, China, Dec. 12, 2025 -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18 at Peking Union Medical College Hospital (PUMCH) in Beijing. This important milestone represents a significant step forward in developing new therapies for Duchenne Muscular Dystrophy (DMD), providing a revolutionary treatment that could benefit all patients affected by this condition. The IIT is led by Professor Dai Yi, a distinguished expert in neuromu
香港、2025年12月12日 -- 香港を代表するショッピングモール「ハーバーシティ」は、イラストレーター兼アーティストコンビ「Sundae Kids」とのコラボにより、今年のクリスマスシーズンに「愛の糸」と題した魅惑的なアートプロジェクトを開催します。この二人のアーティストはタイを拠点に活動しており、心温まる漫画で世界中に200万人以上のファンを持っています。このイベントは2025年11月29日から2026年1月4日まで開催されますが、世界中の人を虜にする独創性とクリスマスシーズンの温もりに満ちた幻想的な体験に浸ることができます。 PoysianとKavinの芸術家カップルが結成したSundae Kidsは、4~6コマの独特の漫画で日常生活の愛と絆のときを温かく共感できる形で描くことで知られています。二人は独特な物語表現の手法により、アジアで最も影響力を持つイラストレーターコンビとしての名声を得ています。 アートプロジェクト「愛の糸(Threads of Love)」の目玉は、息をのむような巨大なピンクのギフトハウス「あなたへのプレゼント」であり、注目の的となること間違いなしでしょう。また、新たに制作された4点の大型アクリル絵画と12点のイラストも展示され、クリスマスの高揚感を表現しています。また、「愛の糸」専用の期間
[ 메디채널 김갑성 기자 ] Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential best-in-class oral PHD inhibitor with IND clearance granted in 2023. The partnership combines Insilico's generative AI discovery platform with TaiGen's regional clinical and commercial expertise to accelerate the development of ISM4808 for the treatment of Anemia of Chronic Kidney Disease (CKD). CAMBRIDGE, Mass., Dec. 12, 2025 -- Insilico Medicine ("Insilico"), a clinical-stage generativ
COLOGNE, Germany, Dec. 12, 2025 -- Smartee Denti-Technology hosted its first GS-focused clinical summit in Cologne on November 27, deepening its collaboration with orthodontists across the DACH region. Although Smartee has operated in Germany for more than 2 years through its local subsidiary, the Cologne meeting marks the company's first European event dedicated specifically to GS mandibular repositioning technology. The following day, Smartee participated in the TPAO Congress, where Chief Scientist Prof. Gang Shen delivered an invited keynote lecture on GS technology—highlighting the growin